The Levels of Glutathione and Nitrite-Nitrate and the Expression of BCL-2 MRNA in Ovariectomized Rats Treated by Raloxifene Against Kainic Acid

REFERENCES

• Adams J. M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281(5381)1322–1326
   PubMed Web of Science ®Google Scholar
• Aizenman E., Brimecombe J. C., Potthoff W. K., Rosenberg P. A. Why is the role of nitric oxide in NMDA receptor function and dysfunction so controversial?. Progress in Brain Research 1998; 118: 53–71
   PubMedGoogle Scholar
• Azcoitia I., DonCarlos L. L., Garcia-Segura L. M. Estrogen and brain vulnerability. Neurotoxicity Research 2002; 4(3)235–245
   PubMedGoogle Scholar
• Azcoitia I., Fernandez-Galaz C., Sierra A., Garcia-Segura L. M. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. Journal of Neurocytology 1999; 28(9)699–710
   PubMedGoogle Scholar
• Bories P. N., Bories C. Nitrate determination in the biological fluids by an enzymatic one-step assay with nitrate reductase. Clinical Chemistry 1995; 41(6)904–907
   PubMed Web of Science ®Google Scholar
• Callier S., Morissette M., Grandbois M., Pelaprat D., Di Paolo T. Neuroprotective properties of 17beta-estrodiol, progesteron and raloxifene in MPTP C57B1/6 mice. Synapse 2001; 41: 131–138
   PubMed Web of Science ®Google Scholar
• Ceccon M., Giusti P., Facci L., Borin G., Imbesi M., Floreani M., et al. Intracellular glutathione levels determine cerebellar granule neuron sensitivity to excitotoxic ınjury by kainic acid. Brain Research 2000; 862: 83–89
   PubMedGoogle Scholar
• Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15: 532–537
   PubMed Web of Science ®Google Scholar
• Ciriza I., Azcoitia I., Garcia-Segura M. Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. Journal of Neuroendocrinology 2004; 16: 58–63
   PubMed Web of Science ®Google Scholar
• Contestabile A., Ciani E. Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochemistry International 2004; 45: 903–914
   PubMed Web of Science ®Google Scholar
• Cooper A. J., Kristal B. S. Multiple roles of glutathione in the central nervous system. Biological Chemistry 1997; 378(89)793–802
   PubMedGoogle Scholar
• Dawson V. L., Dawson T. M. Nitric oxide in neurodegeneration. Progress in Brain Research 1998; 118: 215–229
   PubMed Web of Science ®Google Scholar
• Delen-Akcay Y., Yalcin A., Yıldırım-Sozmen E. The effect of melatonin on lipid peroxidation and nitrite/nitrate levels, and on superoxide dismutase and catalase activities in kainic acid–induced injury. Cellular and Molecular Biology Letters 2005; 10: 321–329
   PubMedGoogle Scholar
• Dringen R. Metabolism and functions of glutathione in brain. Progress in Neurobiology 2000; 62: 649–671
   PubMed Web of Science ®Google Scholar
• Farinelli S. E., Park D. S., Greene L. A. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. Journal of Neuroscience 1996; 16: 2325–2334
   PubMed Web of Science ®Google Scholar
• Garcia-Segura L. M., Azcoitia I., DonCarlos L. L. Neuroprotection by estradiol. Progress in Neurobiology 2001; 63: 29–60
   PubMed Web of Science ®Google Scholar
• Gerlach M., Ben-Shachar D., Riederer P., Youdim M. B. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. Journal of Neurochemistry 1994; 63(3)793–807
   PubMed Web of Science ®Google Scholar
• Grandbois M., Morissette M., Callier S., Di Paolo T. Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice. NeuroReport 2000; 11: 343–346
   PubMed Web of Science ®Google Scholar
• Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241–251
   PubMed Web of Science ®Google Scholar
• Howard S., Bottino C., Brooke S., Cheng E., Giffard R. G., Sapolsky R. Neuroprotective effects of bcl-2 overexpression in hippocampal cultures: Interactions with pathways of oxidative damage. Jounal of Neurochemistry 2002; 83: 914–993
   PubMed Web of Science ®Google Scholar
• Jia W., Wang Y., Qiang D., Tufaro F., Remington R., Cynader M. A bcl-2 expressing viral vector protects cortical neurons from excitotoxicity even when administered several hours after the toxic insult. Brain Research Molecular Brain Research 1996; 42: 350–358
   PubMedGoogle Scholar
• Krishnan M., Dhandapani-Darrell W. B. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biology of Reproduction 2002; 67: 1379–1385
   PubMed Web of Science ®Google Scholar
• Lipton S. A., Choi Y. B., Sucher N. J., Chen H. S. Neuroprotective versus neurodestructive effects of NO-related species. Biofactors 1998; 8: 33–40
   PubMedGoogle Scholar
• Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin-phenol reagent. Journal of Biological Chemistry 1951; 193: 265–375
   PubMed Web of Science ®Google Scholar
• Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human B lymphocyte inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79(7)1137–1146
   PubMedGoogle Scholar
• Marini H., Altavilla D., Bellomo M., Adamo E. B., Marini R., Laureanti F., et al. Modulation of IL-1 Beta gene expression by lipid peroxidation inhibition after kainic acid–induced rat brain injury. Experimental Neurology 2004; 188: 178–186
   PubMed Web of Science ®Google Scholar
• Mehta S. H., Dhandapani K. M., De Sevilla D. M., Webb R. C., Mabesh V. B., Brann D. W. Tamoxifene, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized rats. Neuroendocrinology 2003; 77: 44–50
   PubMed Web of Science ®Google Scholar
• O’Neill K., Chen S., Brinton R. D. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Experimental Neurology 2004; 185: 63–80
   PubMed Web of Science ®Google Scholar
• Oge A., Sezer E. D., Ozgonul M., Bayraktar F., Sozmen E. Y. The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovariectomized rats. Neuroscience Letters 2003; 338: 217–220
   PubMed Web of Science ®Google Scholar
• Osuka K., Feustel P. J., Mongin A. A., Tranmer B. I., Kimelberg H. K. Tamoxifene inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. Journal of Neurochemistry 2001; 76: 1842–1850
   PubMed Web of Science ®Google Scholar
• Ouyang Y., Giffard R. G. Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 2004; 36: 303–311
   PubMed Web of Science ®Google Scholar
• Phillips R. G., Lawrence M. S., Ho D. Y., Sapolsky R. M. Limitations in the neuroprotective potential of gene therapy with Bcl-2. Brain Research 2000; 859: 202–206
   PubMed Web of Science ®Google Scholar
• Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399(6735)483–487
   PubMed Web of Science ®Google Scholar
• Vander Heiden M. G., Chandel N. S., Williamson E. K., Schumacker P. T., Thompson C. B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91: 627–637
   PubMed Web of Science ®Google Scholar
• Velardez M. O., Poliandri A. H., Cabilla J. P., Bodo C. C. A., Machiavelli L. I., Duvilanski B. H. Long term treatment of anterior pituitary cells with nitric oxide induces programmed cell death. Endocrinology 2004; 145(4)2064–2070
   PubMed Web of Science ®Google Scholar
• Voehringer D. W., Meyn R. E. Redox aspects of Bcl-2 function. Antioxidants & Redox Signalling 2000; 2: 537–550
   PubMed Web of Science ®Google Scholar
• Yalcin A., Kanit L., Durmaz G., Sargın S., Terek C. H., Tanyolac B. Altered level of apurinic/apyrimidinic endonuclease/redox factor-1 (APE/REF-1) mRNA in the hippocampus of ovariectomized rats treated by raloxifene against kainic acid. Clinical and Experimental Pharmacology and Physiology 2005; 32(8)611–614
   PubMedGoogle Scholar
• Zhao H., Yenari M. A., Cheng D., Sapolsky R. M., Steinberg G. K. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. Journal of Neurochemistry 2003; 85: 1026–1036
   PubMed Web of Science ®Google Scholar
• Zhao L., O’Neill K., Brinton R. D. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Research Reviews 2005; 49(3)472–493
   PubMedGoogle Scholar